143 related articles for article (PubMed ID: 34315108)
1. Ex vivo susceptibility to new antimalarial agents differs among human-infecting Plasmodium species.
van Schalkwyk DA; Moon RW; Duffey M; Leroy D; Sutherland CJ
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():5-11. PubMed ID: 34315108
[TBL] [Abstract][Full Text] [Related]
2. Cation ATPase (ATP4) Orthologue Replacement in the Malaria Parasite Plasmodium knowlesi Reveals Species-Specific Responses to ATP4-Targeting Drugs.
Mohring F; van Schalkwyk DA; Henrici RC; Blasco B; Leroy D; Sutherland CJ; Moon RW
mBio; 2022 Oct; 13(5):e0117822. PubMed ID: 36190127
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum.
van Schalkwyk DA; Blasco B; Davina Nuñez R; Liew JWK; Amir A; Lau YL; Leroy D; Moon RW; Sutherland CJ
Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():93-99. PubMed ID: 30831468
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents.
van Schalkwyk DA; Moon RW; Blasco B; Sutherland CJ
J Antimicrob Chemother; 2017 Nov; 72(11):3051-3058. PubMed ID: 28961865
[TBL] [Abstract][Full Text] [Related]
5. The WorldWide Antimalarial Resistance Network Clinical Trials Publication Library: A Live, Open-Access Database of
Takata J; Sondo P; Humphreys GS; Burrow R; Maguire B; Hossain MS; Das D; Commons RJ; Price RN; Guerin PJ
Am J Trop Med Hyg; 2020 Jul; 103(1):359-368. PubMed ID: 32431267
[TBL] [Abstract][Full Text] [Related]
6. Assessment
Yipsirimetee A; Chiewpoo P; Tripura R; Lek D; Day NPJ; Dondorp AM; Pukrittayakamee S; White NJ; Chotivanich K
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0148121. PubMed ID: 34978886
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
Kreutzfeld O; Tumwebaze PK; Okitwi M; Orena S; Byaruhanga O; Katairo T; Conrad MD; Rasmussen SA; Legac J; Aydemir O; Giesbrecht D; Forte B; Campbell P; Smith A; Kano H; Nsobya SL; Blasco B; Duffey M; Bailey JA; Cooper RA; Rosenthal PJ
Microbiol Spectr; 2023 Jun; 11(3):e0523622. PubMed ID: 37158739
[TBL] [Abstract][Full Text] [Related]
8. Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.
Phyo AP; Jittamala P; Nosten FH; Pukrittayakamee S; Imwong M; White NJ; Duparc S; Macintyre F; Baker M; Möhrle JJ
Lancet Infect Dis; 2016 Jan; 16(1):61-69. PubMed ID: 26448141
[TBL] [Abstract][Full Text] [Related]
9. Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana.
Aniweh Y; Soulama A; Chirawurah J; Ansah F; Danwonno HA; Sogore F; Rouillier M; Campo B; Amenga-Etego L; Djimde AA; Awandare GA; Dembele L
Microbiol Spectr; 2023 Jun; 11(3):e0491622. PubMed ID: 37093000
[TBL] [Abstract][Full Text] [Related]
10. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
13. Limitations of microscopy to differentiate Plasmodium species in a region co-endemic for Plasmodium falciparum, Plasmodium vivax and Plasmodium knowlesi.
Barber BE; William T; Grigg MJ; Yeo TW; Anstey NM
Malar J; 2013 Jan; 12():8. PubMed ID: 23294844
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
15. The antimalarial ferroquine: from bench to clinic.
Biot C; Nosten F; Fraisse L; Ter-Minassian D; Khalife J; Dive D
Parasite; 2011 Aug; 18(3):207-14. PubMed ID: 21894260
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
[TBL] [Abstract][Full Text] [Related]
17. Novel Endochin-Like Quinolones Exhibit Potent
van Schalkwyk DA; Riscoe MK; Pou S; Winter RW; Nilsen A; Duffey M; Moon RW; Sutherland CJ
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094134
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium malariae and Plasmodium falciparum comparative susceptibility to antimalarial drugs in Mali.
Dembele L; Aniweh Y; Diallo N; Sogore F; Sangare CPO; Haidara AS; Traore A; Diakité SAS; Diakite M; Campo B; Awandare GA; Djimde AA
J Antimicrob Chemother; 2021 Jul; 76(8):2079-2087. PubMed ID: 34021751
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of a gradual dormancy concept in malaria.
Richter J; Franken G; Holtfreter MC; Walter S; Labisch A; Mehlhorn H
Parasitol Res; 2016 Jun; 115(6):2139-48. PubMed ID: 27079460
[TBL] [Abstract][Full Text] [Related]
20.
McCallum FJ; Birrell GW; Chavchich M; Harris I; Obaldia N; Van Breda K; Heffernan GD; Jacobus DP; Shanks D; Edstein MD
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
